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Abstract 
Electrospun grafts are widely investigated for vascular graft replacement due to their ease 
and compatibility with many natural and synthetic polymers. Here, the effect of the 
processing parameters on the scaffold’s architecture and subsequent reactions of partially 
heparinized blood triggered by contacting these topographies were studied. Degrapol® 
(DP) and poly(lactic-co-glycolic acid (PLGA) electrospun fibrous scaffolds were 
characterized with regard to fiber diameter, pore area and scaffold roughness. The study 
showed that electrospinning parameters greatly affect fiber diameter together with pore 
dimension and overall scaffold roughness.  
Coagulation cascade activation, early platelet adhesion and activation were analyzed after 
two hours exposure of blood to the biomaterials. While no differences were found 
between DP and PLGA with similar topographies, the blood reactions were observed to 
be dependent on the fiber diameter and scaffold roughness. Scaffolds composed of thin 
fibers (diameter < 1µm) triggered very low coagulation and almost no platelet adhered. 
On the other hand, scaffold with bigger fiber diameter (2-3 µm) triggered higher 
thrombin formation and more platelets adhered. The highest platelet adhesion and 
activations rates as well as coagulation cascade activation were found in blood incubated 
in contact to the scaffolds produced with the biggest fiber diameter (5µm). 
These findings might indicate that electrospun grafts with small fiber diameter (<1µm) 
could perform better with a reduced early thrombogenicity by lower platelets adhesion 
and lower activation of platelets and coagulation cascade. 
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1. Introduction 
In Europe, cardiovascular diseases (CVD) are responsible for about 50 % of all mortality 
causing about 4.3 million deaths per year [1] and in 2008, over 2.6 % of the overall 
population in Europe was admitted in an hospital for CVD [2]. The restriction of blood 
flow by arteriosclerosis thus represents a significant medical burden. If detected early, 
many obstructed blood vessels can be bypassed or replaced by vascular substitutes, 
including arterial autografts, polytetrafluoroethylene (ePTFE) and polyester grafts [3].  
Autografts were observed to be the most successful choice for the repair of smaller 
diameter vascular grafts with primary patency rates of 73 % compared to 47 % for ePTFE 
and 54 % for polyester grafts [4]. The main limitation of autologous grafts is their 
availability and donor site morbidity [3]. Therefore, tissue engineered vascular grafts 
(TEVG) using autologous cells are promising alternatives. While large diameter TEVG 
grafts regenerated successfully in humans with a five-years patency of about 90 % [5], 
small diameter vascular grafts (diameter < 5 mm) are still a challenge [6]. Among the 
main reasons for graft failure of small diameter grafts (anastomotic intimal hyperplasia, 
aneurysm formation, infection, and progression of atherosclerotic disease), acute 
thrombogenicity of the graft is one of the most important [7-9]. 
Reduction of thrombogenicity is crucial for improving the graft success rate, and several 
strategies have been developed with partial success. The most studied graft surface 
modifications consist in the addition of anti-thrombotic factors, coating with cell-
adhesion ligands to promote endothelialization or seeding with endothelial cells. 
Nevertheless, addition of soluble anti-thrombotic factors has a time limited activity, 
which eventually stops when the whole drug supply is used up.  Coating with cell 
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adhesive ligands and seeding with endothelial cells both aim at a better 
endothelialization, which provides excellent anti-thrombogenic properties [10]. However, 
coating with cell adhesion ligands remains unspecific to endothelial cells and also 
supports platelets and smooth muscle cells adhesion, leading to clotting and subsequent 
pseudointimal thickening [3]. Also, in vitro endothelialization cannot guaranty full 
coverage of the graft and cells are lost during transplantation, therefore complete 
endothelialization in vivo is not instantaneous and takes at least 10 days [11], thus acute 
thrombogenicity cannot be fully prevented by this strategy. 
Electrospinning has been widely used as a processing method for the design of vascular 
grafts [12, 13] with performances equal or superior to current standard, ePTFE [14]. This 
technique is quite popular as it allows easy production of fibrous tubular scaffolds with 
controllable composition, architecture, fiber diameter and mechanical properties [12, 15, 
16]. Scaffold properties tremendously affect the reaction of contacting cells and tissues; 
for instance, scaffold porosity affects the cell infiltration in vitro [15, 16] and tissue 
integration in vivo [17] and fiber orientation can affect cell alignment [18]. Regarding 
vascular grafts, a number of studies showed that endothelialization on scaffolds with 
nano-fibers would be improved compared to micro-fiber scaffolds [12, 19].  
Although early thrombosis has been recognized as a major cause of graft occlusion, no 
study has investigated the influence of electrospun graft topography on acute 
thrombogenicity. In the presented study, two polymers – DegraPol® (DP), which has 
been shown to meet essential requirements for vascular grafts such as good 
biocompatibility [20], mechanical properties [16] and hemocompatibility [21], as well as 
FDA-approved poly(lactic-co-glycolic acid) (PLGA), which has been widely exploited 
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for many biomedical applications [22-25], were processed into scaffolds with defined 
fiber diameters. We subsequently evaluated the effects of fiber diameters and of resulting 
surface topography of the electrospun scaffolds on the early coagulation, platelet 
adhesion and activation. The blood coagulation cascade can be activated by a specific 
stimulus such as injury or exposure to a thrombogenic surface. A key enzyme required 
for the activation of the cascade is thrombin triggering the polymerization of fibrinogen 
into fibrin fibrils [26, 27]. Thrombin-antithrombin (TAT) complexes have been used as a 
surrogate marker for thrombin generation [28] and were used in this study as a marker for 
coagulation cascade activation. The aim of this contribution is to understand the effect of 
the scaffolds architecture on the blood reaction in order to be able to design a scaffold 
with minimal acute thrombogenicity. 
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2. Materials and methods 
2.1 Polymers 
The polyester-urethane (trade name DegraPol® (Mw = 70 kDa)) was produced according 
to the procedure described by [29, 30]. The poly(lactic acid-co-glycolic acid) (Resomer®, 
PLGA, Type RG 85:15, Mw = 280 KDa) was obtained from Boehringer Ingelheim, 
Germany. Chloroform (stabilized with ethanol) was obtained from Emanuele Centonze 
SA, Switzerland and Hexa-fluoro Propanol (HFP) was purchased by Sigma. 
 
2.2 Scaffold production by electrospinning and solvent casting 
Fibrous scaffolds were produced with an electrospinning setup, assembled in-house and 
which consisted of a syringe pump (Racel Scientific Instruments Inc., USA), a spinning 
head consisting of a central stainless steel tube, a hollow cylindrical rotating aluminum 
mandrel for fiber collection (length: 100 mm, diameter: 80 mm, wall thickness: 5 mm) 
and a DC high voltage supply (Glassman High Voltage Inc., USA).  
Homogeneous DegraPol solutions were prepared by letting the desired amount of 
polymer dissolve in a HFP-chloroform mixture (wt % 25 : 75) at room temperature (RT) 
overnight, while PLGA solutions were dissolved in chloroform only. The homogeneous 
solutions were loaded into a 2 mL syringe (B. Braun Melsungen AG, Germany) and 
pumped into the spinning heads. Electrospinning parameters, such as the polymer 
concentration, the distance between the spinning head and the collecting mandrel 
(referred to as working distance), the flow rate and the applied voltage between the 
spinning head and the collector, were set for producing electrospun scaffolds with three 
different desired diameter, called ES1, ES2 and ES3 and summarized in Table 1. 
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Uniform smooth polymeric films were used as plain controls to the porous electrospun 
fibrous scaffolds. For production of polymeric films used as controls, a wt 30 % 
DegraPol solution and a wt 10 % PLGA solution (in chloroform) were prepared. The 
solutions were then cast using a stencil with a 500 µm gap on a polytetrafluoroethylene-
coated plate. The films were left under a fume hood until complete evaporation of the 
solvent. The so-produced casted scaffolds are referred as CS throughout the manuscript. 
Out of the polymeric scaffolds, disks of 20 mm diameter were punched out and used for 
blood incubation experiments. 
 
2.3 Scaffold characterization 
Fiber diameters were measured as described [18] using SEM micrographs: first a 
diagonal line was drawn from bottom left to top right of the image and the fiber diameter 
was measured, perpendicular to the fiber length, at the points where the line crossed the 
fiber using ImageJ (http://rsbweb.nih.gov/ij/) after calibration with the scale bar of the 
microscope image. The diameters of the fibers were averaged over all the images of a 
sample (50 fiber diameters measured per sample). Pore area was determined as described 
[12] using SEM micrographs and manually approximating the surface pores (50 pores 
measured per sample).  
Surface roughness was measured by means of stereo-SEM, where a surface is imaged 
twice with conventional SEM, eucentricly tilted (i.e. in the focus plane) by 10° [31]. 
From these two images of the same region of interest 3D information of the surface 
topography was calculated by means of automatic image correlation with specialized 
software (MeX, Alicona, Graz, Austria)[32]. Resulting height profiles were evaluated 
using the window-roughness method, where values above a certain cut-RIIZDYHOHQJWKȜc 
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are identified as waviness and are not included in the surface roughness calculation [33]. 
Here, cut-RIIZDYHOHQJWKZDVVHWDWȜc = 200 µm and surface roughness was expressed as 
Ra, describing the arithmetic average of the absolute values in z-direction.  
Water contact angle was measured using the Ramé-Hart model 100 (Ramé Hart Inc, 
Moutain lakes, NJ, USA) at room temperature. Water drops of 5 µL were used for water 
contact angle measurements in air. 
 
 
2.4 Partially heparinized whole human blood 
Human whole blood from healthy volunteers not taking medication was purchased from 
the local blood bank (Zentrale Blutbank, University Hospital Zürich) and was heparinized 
directly upon withdrawal by using 5 mL vacutainer tubes (BD Vacutainer™ No Additive 
(Z) Plus Tubes) modified with 15 IU sodium heparin (Carl Roth, Karlsruhe, Germany, 
Eur. Ph., 120 IU/mg) resulting in a final concentration of 3 IU heparin/mL blood (as 
proposed in [31]). All blood samples used for the experiments were freshly withdrawn, 
transported and stored at room temperature and were used within 2 hours. 
 
2.5 Slide chamber, blood incubation and preparation of samples  
Polymeric scaffolds were incubated with partially heparinized whole human blood within 
a rotating slide chamber similar to one described earlier [34]. In brief polymeric scaffolds 
were assembled on both sides of a Teflon ring of 12 mm inner diameter and 10 mm 
height and clamped between two stainless steel plates creating a circular chamber with a 
final volume of 1.1 mL. The closed chambers were filled with blood through a syringe 
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port and incubated for 10 minutes or 2 hours under rotation at 6.6 rpm in an incubator 
(B6030, Heraeus, Hanau, Germany) at 37 °C. 
 
2.6 Enzyme linked immunoassays (ELISA) for the detection of Thrombin-
antithrombin (TAT) 
For analysis of TAT before and after incubation the blood was collected and EDTA was 
added to a final concentration of 5 mM. Subsequently the blood was centrifuged for 10 
minutes at 2’000 g at room temperature and the supernatants were stored at -20 °C until 
further analysis. 
Concentrations of TAT complexes were determined using commercially available ELISA 
kits (AssayMax Human Thrombin-antithrombin (TAT) Complexes). The assay was 
carried out according to the manufacturer’s instructions and with reagents provided by 
the manufacturers. Blood incubated with sand blasted titanium (as described by [35]) 
disks were used as positive control. The experiments were performed at least 4 times in 
duplicates. 
 
2.7 Scanning electron microscopy (SEM)  
Scaffolds were analyzed by SEM before and after 10 min and 2 h of incubation in 
heparinized (3 IU/mL) whole human blood at 37 °C. Briefly, following blood incubation, 
samples were carefully rinsed 3 times in PBS (Sigma) and fixed in 3 % glutaraldehyde in 
PBS for 30 minutes, followed by 2 % osmiumtetroxid in PBS for 20 minutes, both at RT. 
Samples were subsequently dehydrated in a graded series of ethanol (from 30 % to 96 
%). Out of absolute ethanol the samples were dried over the critical point of CO2 (Tk = 
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31.8 °C, Pk = 73.8 bar) using a critical-point dryer (CPD 030 Critical Point Dryer, Bal-
Tec AG, Balzers, Liechtenstein). The samples were sputter-coated with 7 nm platinum 
and the images were recorded with a Zeiss SUPRA 50 VP at 10 kV using secondary 
electron signals.  
Stereo-SEM analysis was performed on all samples, the same ROI being imaged twice 
with the stage eucentricly tilted by 10° between the two images. From these pairs of 
images, 3D data were calculated by means of specialized software (MeX from Alicona, 
Graz Austria). 
 
2.8 Confocal laser scanning microscopy (CLSM) 
For confocal laser-scanning microscopy of deposited blood components, blood-exposed 
scaffolds with different topographies were carefully rinsed 3 times in PBS and 
VXEVHTXHQWO\ ¿[HG IRU  PLQXWHV LQ DQ DTXHRXV VROXWLRQ RI  % (w/v) PFA, 65 mM 
PIPES, 25 mM HEPES, 10 mM EGTA and 3 mM MgCl2 and subsequently incubated for 
10 minutes in PBS containing 0.1 % Triton X 100 (500 µL per well) for cell 
permeabilization. On all samples, cell nuclei were stained with 1:2000 Hoechst 33342 
(Molecular Probes) in PBS containing 1 % (w/w) of BSA (Bovine Serum Albumin, 
SAFC, USA) for 10 minutes at RT. Staining of the actin cytoskeleton was achieved by 
incubating the samples in a solution of Alexa Fluor® 488-phalloidin (1:200, Molecular 
Probes) in 1 % (w/w) of BSA in PBS for 2 hours at RT. 
P-Selectin was carried out by incubating the samples in solutions of purified anti-human 
CD62P – P-Selectin (Biolegend, No 304902) using 1:50 dilutions for 2 hours followed by 
incubation in a solution of anti-mouse Alexa 633 (1:200, Molecular Probes) for 1 hour at 
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RT. Samples were washed 3 times with PBS after incubation with antibody solutions. All 
antibodies were diluted in 1 % (w/w) BSA in PBS. Samples were mounted on glass 
coverslips (24 x 50 mm, Carl Roth, Karlsruhe, Germany) using Mowiol 4-88 mounting 
media (Calbiochem, Damstadt, Germany), left overnight and analyzed by laser scanning 
confocal microscopy (SP5, Leica Microsystems, Germany). Fluorescence was analyzed 
using the following wavelengths: Hoechst 33342 (ex = 350 nm and em= 440 nm), Alexa-
488 (ex = 495 nm and em = 519 nm) and Alexa-633 (ex = 632 nm and em = 647 nm). 
 
2.9 Statistical analysis 
All mean values were compared by two-way ANOVA analysis using Matlab 7.9 (the 
MathWorks Inc, USA). Statistical significance was accepted for p < 0.05 after comparing 
the mean values by Bonferroni post hoc test and was designated by an asterisk. 
Trendlines and fitting in Figure 1j and 2k were also calculated with Matlab. Throughout 
the manuscript the data is presented as a mean ± standard deviations. 
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3. Results 
 
3.1 Morphology, roughness and wettability of the DegraPol scaffolds 
Scaffolds with 3 defined fiber diameter and surface architecture were produced by 
electrospinning and referred as ES1, ES2 and ES3. Figure 1 represents SEM micrographs 
showing the morphology of the DegraPol (Figure 1 a-d) and PLGA (Figure 1 e-h) 
surfaces. The fiber diameters of the different scaffolds are shown in Figure 1 i. In brief, 
on the solvent cast films (Figure 1 a and e) no fiber diameter was measured, ES1 
scaffolds had an average diameter below one micrometer (0.93 ± 0.33 µm for DP and 
0.63 ± 0.09 µm for PLGA, Figure 1 b and f respectively), while ES2 scaffolds were 
comprised between 2 and 3 µm (2.67 ± 0.63 µm for DP and 2.06 ± 0.31 µm for PLGA, 
Figure 1 c and g respectively). Lastly, ES3 scaffolds for DP were composed of fibers 
with a mean diameter of 6.52 ± 1.53 µm, while PLGA showed a mean diameter of ES3 
5.02 ± 0.75 µm (Figure 1 d and h respectively). No significant difference was found 
between DP and PLGA (for CS, ES1, ES2 and ES3), while the different classes of 
scaffold were significantly different from each other (see Figure 1 i). Areas of the surface 
pores were calculated and reported in Figure 1 j. Casted scaffolds (CS) not having fibers, 
no pore was determined for these scaffolds, pores on fibrous scaffolds increased with the 
diameter, for both DegraPol scaffolds (for which ES1, ES2 and ES3 had mean pore areas 
of 43 ± 29 µm2, 368 ± 208 µm2 and 1623 ± 858 µm2, respectively) as for PLGA scaffolds 
(for which the pore areas increased from 33.9 ± 20 µm2 for ES1, to 226 ± 147 µm2 for 
ES2 and finally 988 ± 779µm2 for ES3). Nevertheless, no differences in pore area were 
found between DP and PLGA scaffolds for similar fiber diameters (Figure 1 j). In 
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addition, the pore area of the scaffolds, seem to vary in a quadratic way compared to the 
fiber diameter, as the R2 value with a quadratic trend line fit was 0.993  (Figure 1 k). 
Roughness of the scaffolds was assessed by analysis of stereo-SEM pairs (Figure 2 a-h), 
the surface roughness Ra of the scaffolds was found to increase with the diameter of the 
constituting fibers. Solvent casted scaffolds were found to be the smoothest with a 
roughness of 0.36 ± 0.01 µm for DP and 0.42 ± 0.05 µm for PLGA, followed by ES1 
scaffolds, 1.46 ± 0.08 µm for DP and 1.50 ± 0.07 for PLGA, ES2 scaffolds, 3.90 ± 0.27 
µm for DP and 3.94 ± 0.08 for PLGA, and finally ES3 scaffolds had the highest Ra values 
(6.26 ± 0.69 µm for DP and 5.00 ± 0.21 for PLGA). Scaffold roughness was found to be 
dependent on processing conditions, but independent of the polymer used (Figure 2 i). 
Fitting the roughness-diameter curve for both PLGA and DP, R2 value with a linear 
trendline fit was 0.902  (Figure 2 j). 
Water contact angle of all polymeric scaffolds were measured (Table 2). While no 
significant difference was found between PLGA and DP, processing parameters affect the 
scaffold wettability. The CS were found to be much less hydrophobic than the other 
scaffolds (73.1 ± 2.6 ° and 76.6 ± 13.1 ° for DP ad PLGA respectively). The scaffolds 
with the smallest fibers were found to be a little bit more hydrophobic (128.6 ± 4.2 ° for 
DP and 122.8 ± 3.5 ° for PLGA) than ES2 and ES3 (all comprised between 116.3 ± 5.3 
and 118.7 ± 1.9 °). 
 
3.2 Blood activation by the different polymeric scaffolds 
To analyze the differences between the adhesion and activation of platelets depending on 
the surface characteristics, namely fiber diameter and pore size, the different scaffolds, 
after incubation in blood, were characterized by confocal laser-scanning microscopy after 
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staining with specific antibodies, while the blood was tested for TAT levels as indicators 
of coagulation cascade activation, after 2 hrs of incubation with whole blood. 
Platelet adhesion and activation in the blood clots were analyzed by (immuno-)stainings 
of a platelet surface marker CD62p, the actin cytoskeleton and cell nuclei on the 
polymeric surfaces. The total quantity of cells was determined by nuclear staining while 
the antibody against CD62p was used to stain persistently activated platelets. Figure 4 A-
H show projections of z-stacks obtained by confocal laser-scanning microscopy images 
of blood clots formed on polymer cast- and electrospun scaffolds.  
The surface coverage by activated CD62p-positive platelets as well as the ratio of 
activated versus nonactivated platelets is indeed greatly affected by the topography of the 
scaffold (Figure 4 i and j). Independent of the polymer used, the overall coverage by 
platelets was increased on electrospun scaffolds with increasing fiber diameter. For DP 
(Figure 4 i), total coverage was increasing from ES1 – 4.5 ± 2.5 %, to ES2 – 19.7 ± 12.6  
%, until maximal values for ES 3 of 45.8 ± 13.0 %. In a similar manner, ES1, ES2 and 
ES 3 PLGA scaffolds were covered at 4.2 ± 0.7 %, 15.8 ± 2.5 % and 36.0 ± 7.0 % 
respectively (Figure 4 i). No difference between DP and PLGA electrospun scaffolds 
were found. The solvent cast scaffolds were found to be comparable to ES1 for DP and 
PLGA scaffolds. 
For platelet activation, no difference could be found comparing DP to PLGA scaffolds 
(Figure 4 j). For both polymers, the activation remained lower for CS, ES1 and ES2 
(respectively 1.2 ± 0.9 %, 1.0 ± 0.8 % and 1.6 ± 1.9 % for DP and 0.5 ± 0.2 %, 1.0 ± 0.2 
% and 1.2 ± 0.6 % for PLGA); while it was significantly increased in ES3 (13.4 ± 5.3 % 
for DP and 14.8 ± 3.5 % for PLGA). 
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Thrombin-antithrombin complexes indicate an activated coagulation cascade and are 
correlated to the extent of blood activation. TAT levels in blood were not different if 
exposed to PLGA or DegraPol (Figure 4). Concerning the effect of surface topography, 
the protein levels in blood incubated with the two smoothest surfaces (CS and ES1) were 
not increased compared to before activation (14.1 ± 2.9 ng/mL). Rougher surfaces 
triggered an increase in TAT complexes; for ES2 surfaces values increased significantly 
to 24.4 ± 9.8 ng/mL for DegraPol scaffolds and 24.9 for PLGA ones. Even higher values 
were measured for the roughest surfaces of ES3 (57.1 ± 19.8 ng/mL for DP and 36.0 ± 
10.4 ng/mL for PLGA). 
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4. Discussion  
 
Designing blood contacting medical devices in general, and vascular grafts in particular, 
has to consider how to up- or down-regulate blood-material reactions to prevent adverse 
reactions or failure. In case of small diameter TEVG by electrospinning, early thrombus 
formation often causes graft failure. Studies have aimed at improving the 
thrombogenicity of TEVG by changing the surface properties [36, 37], adding 
antithrombotic drugs [36, 38], or growing an endothelium on the graft prior to 
implantation [39, 40]. Although electrospun vascular scaffolds with fiber diameters 
varying from couple of hundreds of nm [12] up to 6 µm [41], in vitro and from about 500 
nm [42] to over 3 µm [43] in vivo were used in recent publications, the effect of fiber 
diameter and their topography on thrombogenicity was never addressed. For this 
purpose, electrospun scaffolds of DegraPol and PLGA were produced and characterized 
with various defined fiber diameters. It is known and here confirmed that fiber diameter 
dictates other surface properties, as the pore size [12, 44] and the surface roughness [45] 
increase with increasing constituting fiber diameter.  
 
While assessing the thrombogenicity of the defined scaffold varying in chemistry and 
topography, our major finding is that the blood reaction, namely platelet adhesion and 
activation, is far more affected by the scaffold morphology than by differences in the 
polymers chemistries used (Figure 3 and 4).  
For similar scaffold morphologies (i.e. constituting fiber diameter) DegraPol and PLGA 
performed in a similar way. DegraPol and PLGA flat surfaces were already shown to 
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trigger comparable changes in protein levels in blood [21]. More in details, when 
analyzing the protein levels in blood after 2 hours exposure to flat surfaces of PLGA and 
DegraPol, no differences were found in blood activation in terms of coagulation cascade 
activation (evaluating TAT levels), complement system activation (C5a levels) and, more 
interestingly, platelet activation (PF4 levels) [21]. Similar activation on DP and PLGA 
surfaces, could be explained by their comparable hydrophilicity (as already reported in 
the literature for DP films: 65 - 79° (Henry et al., 2006) and PLGA films contact angle: 
72 ± 3° [46]), which influences thrombogenicity [47]. This emphasizes furthermore the 
importance of the scaffold topography in thrombogenicity of the construct. 
Interestingly and to our knowledge never described before, coagulation cascade, platelet 
adhesion and activation were observed to depend on the average fiber diameter of the 
scaffold. Scaffolds with fibers smaller than 1µm induced a lower coagulation cascade 
activation and platelet adhesion when compared to scaffolds composed of bigger fibers. 
Our findings with electrospun fibers thus agree with conclusion derived from utilizing 
other types of surface topographies: it has been widely observed that platelet adhesion 
and blood reaction both depend on surface roughness [48-52], and that platelet adhesion 
and blood activation are also affected by other defined surface topographies, i.e. pillars 
[53], lenses [54] and struts [55]. All the data taken together suggests that reducing the 
size of surface features (pillars, lenses, struts, or here fibers) might lead to a reduction of 
the contacting blood activation. Still, not only the size of the surface features  matters, but 
also their aspect ratio, distribution and packing density [53]. Concerning electrospun 
fibers, aspect ratio doesn’t vary with fiber diameter, but to some extent, it is possible to 
adjust the fiber distribution and density [56]. This could be an additional way of tuning 
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the thrombogenicity of electrospun fibers. Other properties of the scaffold might play a 
role in differential blood activation with changing fiber diameter. Indeed, scaffold 
wettability is also affected by fiber diameter and roughness in general. In accordance, 
with Cui et al, scaffolds with smaller fibers were found to be a little bit more hydrophobic 
than scaffolds with bigger fibers [57]. Nevertheless, CS and ES1 (which have equivalent 
roughness) are respectively the most hydrophilic and most hydrophobic scaffolds tested 
in the present study and are still performing similarly in terms of thrombogenicity. This 
emphesizes that wettability alone cannot explain the presented results, and that roughness 
changes very likely are responsible for differential blood activation. 
 
Exploiting electrospinning to alter surface topographies has the advantage that it is 
relatively easy to control the processing parameters to tune fiber diameters, and is far 
cheaper than producing micro- or nanofabricated materials. Straightforward and cheap to 
produce, solvent casted films were used as controls due to their low roughness and good 
reproducibility. Throughout the experiments, they showed very good performance in 
terms of blood activation, which could imply that solvent casted films could also be good 
candidates to reduce thombogenicity. However, their major disadvantage remains the 
lack of porosity, crucial for exchanges between the different layers, nutrient supply or 
chemical signaling from endothelial cells that guide organization of the growth and 
development of connective tissue cells that form the surrounding layers [58]. While 
reducing thrombogenicity, electrospun scaffolds with submicrometer-fibers have a 
limited cell infiltration [12, 59], which is a requirement for functional vascular substitute 
with a good tissue integration and healthy smooth muscle cell layer. Therefore, sub-
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micrometer fibers are not suited for muscle layer development, and several strategies 
were developed for increasing the pore size of electrospun scaffolds, including salt 
leaching, use of sacrificial fibers, ice crystals as void templates, or gas foaming (reviewed 
in [60]). Scaffolds with greater pore sizes were observed to support enhanced smooth 
muscle cell infiltration compared to denser scaffold and are therefore better suited for 
supporting the muscle layer formation [12]. In addition, mechanical properties of scaffold 
with thinner diameter have reduced mechanical properties, possibly affecting the graft 
stability [15]. An optimize graft should contain at least another layer promoting muscle 
layer formation and graft stability. 
 
5. Conclusion 
Vascular grafts should display two main features: acute thrombogenicity should not only 
be avoided, but it should also promote a good tissue regeneration for full function 
recovery. Two parts of the vessel are key for its functionality: the endothelium that 
actively interacts with blood and the smooth muscle layer providing contractility to the 
organ.  Our finding that electrospun scaffold fibers with increasing diameter showed an 
increase in platelet adhesion and activation, and coagulation cascade activation in vitro 
now suggests a new avenue how to improve upon electrospun scaffold designs.  
Although in vivo experiments should be carried out to confirm the results of our in vitro 
model, electrospun vascular graft should probably be composed from multiple layers: an 
inner layer being less thrombogenic and supporting a more rapid endothelialization, and 
an outer layer promoting an improved surrounding tissue integration and providing 
mechanical stability to the graft. Indeed, the endothelial cell function, spreading and 
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proliferation were observed to be enhanced on sub-micrometer fibers [12, 19, 45, 61, 
62]. At least for endothelial cells, it was reported that they adhered and proliferated 
better on thinner fibers compared to microfibers, and that cells on sub-micrometer, to 1.2 
µm fibers spread while they remained round-shaped and non-proliferating on 7 µm 
diameter fibers [19]. Those results suggest that scaffolds with sub-micrometer fibers 
might support a faster endothelialization. 
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Table 1: Electrospinning parameters used for the production of the different DegraPol  
and PLGA fibrous-scaffolds. The concentration represents the weight portion of polymer 
in the solvent mixture (25% HFP and 75% Chloroform was used for DegraPol and pure 
Chloroform was used for PLGA). 
Polymer Scaffold Concentration Flow rate Working distance Applied voltage 
DegraPol 
ES1 15 % 0.1 mL/h 25 cm 5 kV 
ES2 25 % 0.4 mL/h 20 cm 10 kV 
ES3 25 % 1 mL/h 15 cm 15 kV 
PLGA 
ES1 15 % 0.4 mL/h 25 cm 10 kV 
ES2 25 % 1 mL/h 20 cm 10 kV 
ES3 25 % 1.5 mL/h 15 cm 10 kV 
 
 
Table 2: Water contact angle measurements of the polymeric scaffolds. 
Polymer Scaffold Water Contact Angle [°] 
DegraPol 
CS 73.1 ± 2.6 
ES1 128.6 ± 4.2 
ES2 116.3 ± 5.3 
ES3 118.7 ± 1.9 
PLGA 
CS 76.6 ± 13.1 
ES1 122.8 ± 3.5 
ES2 117.5 ± 5.9 
ES3 118.5 ± 2.4 
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Figure legends 
Figure 1: SEM Micrographs of the DP (a-d) and PLGA (e-h) scaffolds. Electrospun 
scaffolds with different fiber diameter ES1-3 (b-e and f-h), and the films used as controls 
CS (a and e). Bar = 20 µm. Mean fiber diameters (i) and pore areas (j) of the scaffolds are 
shown (no values were reported for the film CS). k) represents a graph of the pore area 
compared to the fiber diameter on which the dashed line is a quadratic trend line with 
corresponding R2 value. Asterisks indicate statistical significance (p > 0.05) between the 
two scaffolds classes, while no significant differences were found comparing DP 
scaffolds to PLGA ones. 
 
Figure 2: False-color images indicating the surface topography of the DegraPol (a-d) and 
PLGA (e-h) surfaces. The images were obtained from stereo-pairs form SEM images 
reconstructed with MeX (Alicona), and used for calculation of surface roughness. 
Scaffold roughness (Ra) is shown in i. j) represents a graph of the scaffold roughness 
compared to the fiber diameter on which the dashed line is a linear trendline with 
corresponding R2 value. Asterisks indicate statistical significance (p > 0.05) between the 
two scaffolds classes, while no significant differences were found comparing DP 
scaffolds to PLGA. 
 
Figure 3: Immunofluorescence micrographs of cast (a and e) and electrospun (b-d and f-
h) DegraPol (a-d) and PLGA (e-h) scaffolds after exposure to partially heparinized whole 
human blood for 2 hrs at 37°C. Surfaces were stained with Hoechst (blue) for nuclei, with 
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phalloidin-Alexa 488 conjugate (green) for actin and with anti-CD62p (red) for activated 
platelets. i) represents a quantification of surface coverage by blood cells as determined 
after staining the actin cytoskeleton. j) Represents surface coverage of CD62p-positive-
activated platelets. Bar = 50 µm. Asterisks indicate statistical significance (p > 0.05) 
between the two.  
 
Figure 4: TAT levels in 3 IU heparin/mL whole blood after 2 hours incubation with the 
polymeric scaffolds. The dotted line surrounded by the gray area represent the mean TAT 
levels in blood before incubation and its deviation while the dashed line and the 
surrounding area represents the mean TAT levels in blood after incubation with a highly 
thrombogenic Titanium surface and deviation.  
 




